In human melanoma cell lines, melanoma antigens gp100, MART1, TYRP1, and TYRP2 were upregulated at the mRNA level following treatment with HDAC6 inhibitors (Nexturastat A or Tubastatin A). The gene discussed is HDAC6; the disease is melanoma.